Skip to main content

Fenofibrate Tablets

Type of Posting: Revision Bulletin

Posting Date: 22–Nov–2013

Official Date: 01–Dec–2013

Archive Date: 09–Feb–2015

Expert Committee: Monographs—Small Molecules 2

Reason for Revision: Compliance

In accordance with the Rules and Procedures of the 2010-2015 Council of Experts, the Monographs—Small Molecules 2 Expert Committee has revised the Fenofibrate Tablets monograph. The purpose of the revision is to widen the acceptance criteria listed in Table 1 under Organic Impurities section as follows:

  • Fenofibrate related compound B: from NMT 0.2% to 0.50%.
  • Total impurities: from NMT 0.3% to NMT 1.0%

The Fenofibrate Tablets Revision Bulletin supersedes the currently official monograph. This Revision Bulletin will be incorporated in Second Supplement to USP 37–NF 32

Should you have any questions, please contact Sujatha Ramakrishna Ph.D., MBA (301-816-8349 or sxr@usp.org).